|
MANBA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.315400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.303000E-01 |
| Normal-vs-Stage2 |
8.388400E-01 |
| Normal-vs-Stage3 |
9.951000E-01 |
| Normal-vs-Stage4 |
9.714800E-01 |
| Stage1-vs-Stage2 |
6.567800E-01 |
| Stage1-vs-Stage3 |
7.932200E-01 |
| Stage1-vs-Stage4 |
8.703400E-01 |
| Stage2-vs-Stage3 |
8.196000E-01 |
| Stage2-vs-Stage4 |
8.268200E-01 |
| Stage3-vs-Stage4 |
9.746600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.188800E-01 |
| Normal-vs-AfricanAmerican |
1.200290E-02 |
| Normal-vs-Asian |
7.469200E-01 |
| Caucasian-vs-AfricanAmerican |
2.782600E-03 |
| Caucasian-vs-Asian |
9.851000E-01 |
| AfricanAmerican-vs-Asian |
9.176800E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.504600E-01 |
| Normal-vs-Female |
9.457200E-01 |
| Male-vs-Female |
4.635000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.280000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.728000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.094000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.058800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.349000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.097190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.409200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.061700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.356200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.622790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.875800E-01 |
| Classical-VS-Follicular |
6.047000E-01 |
| Classical-VS-Other |
7.069400E-01 |
| Classical-VS-Normal |
8.924200E-01 |
| Tall-VS-Follicular |
5.913800E-01 |
| Tall-VS-Other |
4.000800E-01 |
| Tall-VS-Normal |
3.814200E-01 |
| Follicular-VS-Other |
6.684200E-01 |
| Follicular-VS-Normal |
7.500800E-01 |
| Other-VS-Normal |
6.646800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.733200E-01 |
| Normal-vs-N1 |
1.224430E-01 |
| N0-vs-N1 |
4.503800E-02 |
|
|
